Subjects aged 12-65. 
Confirmed idiopathic pulmonary hypertension, connective tissue disease associated pulmonary hypertension, congenital heart disease(with Eisenmenger syndrome) associated pulmonary hypertension. 
Baseline 6-minutes walking distance 150m-550m. 
WHO pulmonary hypertension function II-III with non-responder to calcium channel blockers. 
Documented written informed consent. 
